{"id":176,"date":"2015-10-09T14:20:43","date_gmt":"2015-10-09T12:20:43","guid":{"rendered":"http:\/\/semmelweis.hu\/symposium\/?page_id=176"},"modified":"2026-03-16T09:57:20","modified_gmt":"2026-03-16T08:57:20","slug":"semmelweis-symposium-2015","status":"publish","type":"page","link":"https:\/\/semmelweis.hu\/symposium\/en\/archive\/semmelweis-symposium-2015\/","title":{"rendered":"Semmelweis Symposium 2015"},"content":{"rendered":"<p><strong>Semmelweis Symposium 2015: Molecular Oncology: from bench to bedside<\/strong><\/p>\n<p><strong>Larus Conference Center, Budapest<\/strong><\/p>\n<p><em>In association with Federation of Hungarian Medical Associations<\/em><\/p>\n<p><strong><em>5th NOVEMBER, 2015<br \/>\n<\/em><\/strong><br \/>\n9.00-9.15 Opening Ceremony<\/p>\n<p><strong>Morning Session: Experimental cancer research<\/strong><br \/>\nChair person: Hunyady L<\/p>\n<p>9.15-9.30 Nagy P. 1st Institute of Pathology and Experimental Cancer Research, SU: Imatinib\u00a0preserves the functional organization and amends regeneration of liver in CDE fed mice<\/p>\n<p>9.30-9.45 Kovalszky I. 1st Institute of Pathology and Experimental Cancer Research, SU: Tumorstroma\u00a0interaction of hepatomas with slow and fast proliferation rates.<\/p>\n<p>9.45-10.05 Ligeti E. Department of Physiology, SU: Role of Rac\/Rho GTPase activating proteins in\u00a0regulation of cellular functions<\/p>\n<p>10.05-10.20 D\u00f6me B. Department of Thoracic Surgery, SU: Tumor vascularization<\/p>\n<p>10.20-10.35 T\u00edm\u00e1r J, R\u00e1s\u00f3 E.. 2nd Department of Pathology, SU: IFN resistance of melanoma<\/p>\n<p>10.35-10.55 K\u00e9ri Gy. HAS-SU Pathobiochemistry Research Unit: In vitro combination therapy based on\u00a0driver genes<\/p>\n<p>10.55-11.10<em> Coffee break<\/em><\/p>\n<p>11.10-11.25 Enyedi A. HAS-SU Molecular Oncology Research Unit: Ca++ signaling in BRAF mutant\u00a0melanoma<\/p>\n<p>11.25-11.45 Albini A, Fondazio MultiMedica, Milan: Angiogenesis and tumor microenvironment as\u00a0tergets for cancer prevention<\/p>\n<p>11.45-12.00 Noonan D. University of Insubria, Varese: Immune cell polarization in cancer<\/p>\n<p>12.00-12.30 Jalkanen S. Biocity Turku: New tools to target lymphatics in cancer spread<\/p>\n<p><em>12.30-14.00 Lunch break, poster viewing<\/em><\/p>\n<p><strong>Afternoon Session: Cancer genomics<\/strong><br \/>\nChairpersons: Kosztol\u00e1nyi Gy, Mandl J<\/p>\n<p>14.00-14.30 Dietel M. Charit\u00e9, Berlin: Molecular pathology in XXIst century<\/p>\n<p>14.30-15.00 Pat\u00f3cs A. HAS-SU Lend\u00fclet program: Endocrine cancers<\/p>\n<p>15.00-15.30 Sz\u00e1ll\u00e1si Z. HAS-SU Molecular Oncology Research Unit: Opening new avenues for cancer\u00a0treatment by next generation sequencing<\/p>\n<p>15.30-16.00 <em>Coffee break<\/em><\/p>\n<p>16.00-16.15 B\u00f6d\u00f6r Cs HAS-SU Led\u00fclet program: Identification of novel therapeutic targets in follicular\u00a0lymphoma using NGS<\/p>\n<p>16.15-16.30 Gy\u0151rffy B, HAS-SU Lend\u00fclet program: Computing offtarget-effect by cross-analysis of\u00a0transcriptome-level data from 1,118 studies<\/p>\n<p>16.30-16.50, Bock C, CeMM Research Center, Vienna, Epigenomics and single-cell sequencing in\u00a0cancer and beyond<\/p>\n<p>16.50-17.10 Marko-Varga Gy, University of Lund: Threading protein expressions into disease\u00a0surveillance strategy within modern healthcare<\/p>\n<p>17.10-17.30 Jalkanen M, Pharon Pharmeceuticals: SME as a central link between the bench and the\u00a0bedside<\/p>\n<p>17.30- poster viewing<\/p>\n<p>19.00: Dinner and Cultural Evening at Semmelweis Salon: Jazz and wine<br \/>\n(main building, Semmelweis University Campus)<\/p>\n<hr \/>\n<p><strong><em><br \/>\n6th NOVEMBER\u00a02015<br \/>\n<\/em><\/strong><br \/>\n<strong>Morning Session: Molecular Pathology of Cancer<\/strong><br \/>\nChairperson: Olah E.<\/p>\n<p>9.00-9.20 Matolcsy A. 1st Institute of Pathology and Experimental Cancer Research, SU: Molecular\u00a0diagnostics of lymphomas<\/p>\n<p>9.20-9.40 Kiss A. 2nd Department of Pathology, SU: Predictive markers of Sorafenib sensitivity of HCC<\/p>\n<p>9.40-10.00 Lakatos P. 1st Department of \u00cdnternal Medicine, SU: Molecular pathology of thyroid\u00a0cancers<\/p>\n<p>10.00-10.20 S\u00e1pi Z. 1st Institute of Pathology and Experimental Cancer Research, SU: Molecular\u00a0alterations of diagnostic value: eptheloid and synovial sarcomas<\/p>\n<p>10.20-10.40. Sz\u00e1sz AM, 2nd Department of Pathology: Gene expression based novel prognostic\u00a0factors in breast cancer<\/p>\n<p>10.40-11.00 <em>Coffee break<br \/>\n<\/em><br \/>\n11.00-11.20 Heged\u0171s B. Department of Thoracic Surgery, Medical University of Vienna: Oncogenic\u00a0mutations of the EGFR pathway in lung adenocarcinoma<\/p>\n<p>11.20-11.50 Hoefler G, Department of Pathology, Graz: Genetic heterogeneity of colorectal cancer<\/p>\n<p>11.50-12.00 Poster award \u2013 Experimental<\/p>\n<p>12.00-12.10 Poster Award \u2013 Translational<\/p>\n<p><em>12.10-14.00 Lunch Break<\/em><\/p>\n<p><strong>Afternoon Session: Molecular Oncology in Clinic<\/strong><br \/>\nChairperson: Tulassay Zs<\/p>\n<p>14.00-14.15 Demeter J, 1st Department of Internal Medicine, SU: Experience with targeted therapy in\u00a0chronic myeloid leukemia and hairy cell leukemia<\/p>\n<p>14.15-14.30 Dank M. Department of Oncology, SU: AVAREG study<\/p>\n<p>14.30-14.45 Igaz P. 2nd Department of Internal Medicine, SU: MicroRNAs and genomics in adrenal\u00a0tumors<\/p>\n<p>14.45-15.00 Coffee break<\/p>\n<p>15.00-15.30 Schmoll HJ, Martin-Luther University Halle-Wittenberg, Current standards and new\u00a0targets in colorectal cancer<\/p>\n<p>15.30-16.00 Immunooncology TBA<\/p>\n<p>16.00-16.30 Talor E, CelSci, USA: Multikine a novel approach to cancer immunotherapy<\/p>\n<p><em>16.30-16.45 Closing remarks<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Semmelweis Symposium 2015: Molecular Oncology: from bench to bedside Larus Conference Center, Budapest In association with Federation of Hungarian Medical Associations 5th NOVEMBER, 2015 9.00-9.15 Opening Ceremony Morning Session: Experimental cancer research Chair person: Hunyady L 9.15-9.30 Nagy P. 1st Institute of Pathology and Experimental Cancer Research, SU: Imatinib\u00a0preserves the functional organization and amends regeneration &hellip;<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":1846,"menu_order":95,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[],"tags":[],"class_list":["post-176","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/176","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/comments?post=176"}],"version-history":[{"count":1,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/176\/revisions"}],"predecessor-version":[{"id":177,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/176\/revisions\/177"}],"up":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/pages\/1846"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/media?parent=176"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/categories?post=176"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/symposium\/wp-json\/wp\/v2\/tags?post=176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}